Wall Street Analysts Are Bullish on Top Healthcare Picks
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Merck & Company (MRK – Research Report) and ...
Investing Snacks8h
Oppenheimer Cuts Stake in Bristol-Myers Squibb by 8.1%
Oppenheimer & Co. Inc. reduced its stake in Bristol-Myers Squibb by 8.1%, selling nearly 19,000 shares in Q4. The ...
Healio9h
VIDEO: Trial builds on current microsatellite instability-high colorectal cancer therapy
In this video, Arvind N. Dasari, MD, MS, discussed the results of the CheckMate 8HW trial in which nivolumab and ipilimumab were compared with nivolumab monotherapy for microsatellite instability-high ...
Bristol Myers Squibb Co. stock outperforms competitors on strong trading day
Bristol Myers Squibb Co. closed 3.76% short of its 52-week high of $61.10, which the company achieved on January 27th.
Tech Moves: UW professor wins prestigious honor; T-Mobile board shuffle; and more
Mary-Claire King, a groundbreaking innovator in genetics, received The National Academy of Sciences' most prestigious metal.
IPWatchdog17h
Patient Group and Trump DOJ Defend Medicare Pricing Program in Third Circuit Briefs
Patient advocacy group Patients for Affordable Drugs (P4AD) yesterday filed its fourth amicus brief defending the Biden ...
kalkinemedia19h
How Is Bristol-Myers Squibb (NYSE:BMY) Expanding Its Market Influence
Highlights,Bristol-Myers Squibb has seen adjustments in institutional holdings, reflecting shifts in market ...